US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam Pharmaceuticals, Inc. | $301.11 | 1.1% | $40.18B | 129.2 | 301.4% | — | Healthcare | 10.1% | 82.6% | ||
| 2 | Ionis Pharmaceuticals, Inc. | $75.25 | -0.3% | $12.44B | -31.6 | 30.1% | — | Healthcare | 123.6% | 47.5% | ||
| 3 | Arrowhead Pharmaceuticals, Inc. | $74.93 | -1.9% | $10.49B | -6141.8 | 129.7% | — | Healthcare | 436% | 43539.2% | ||
| 4 | CRISPR Therapeutics AG | $52.38 | -2.2% | $4.92B | -8.1 | -97.5% | — | Healthcare | 39.2% | -81.7% | ||
| 5 | Beam Therapeutics Inc. | $28.90 | -3.9% | $2.97B | -35.7 | 77.9% | — | Healthcare | 45.8% | 120% | ||
| 6 | Avidity Biosciences, Inc. | $12.91 | 0.3% | $1.95B | -2.6 | -71.4% | — | Healthcare | -60% | 72.1% | ||
| 7 | Stoke Therapeutics, Inc. | $32.96 | -3.6% | $1.94B | -274.7 | 91.7% | — | Healthcare | 239.8% | 404.5% | ||
| 8 | Intellia Therapeutics, Inc. | $13.31 | -4% | $1.55B | -3.5 | 27.4% | — | Healthcare | 57.7% | -100% | ||
| 9 | Wave Life Sciences Ltd. | $7.18 | -3.9% | $1.38B | -5.9 | -26.2% | — | Healthcare | -7.1% | -31.6% | ||
| 10 | Arbutus Biopharma Corporation | $4.40 | 0.2% | $847M | -25.9 | 55% | — | Healthcare | 25.3% | 128.2% | ||
| 11 | Design Therapeutics, Inc. | $13.41 | 1.8% | $838M | -11.0 | -21.2% | — | Healthcare | 207.6% | — | ||
| 12 | Prime Medicine, Inc. | $3.39 | -2% | $612M | -2.5 | 18.5% | — | Healthcare | 115.9% | 55.3% | ||
| 13 | Silence Therapeutics plc | $7.14 | -2.1% | $337M | -3.8 | -161.7% | — | Healthcare | 82.6% | -98.7% | ||
| 14 | Editas Medicine, Inc. | $3.04 | 1.3% | $298M | -1.7 | 37.5% | — | Healthcare | 97.4% | -100% | ||
| 15 | Arcturus Therapeutics Holdings Inc. | $8.41 | -1.9% | $239M | -3.5 | 20.3% | — | Healthcare | -29.4% | -46.4% | ||
| 16 | CAMP4 Therapeutics Corporation | $3.98 | 3.1% | $187M | -1.5 | 48% | — | Healthcare | 107.3% | — | ||
| 17 | ProQR Therapeutics N.V. | $1.63 | -0.6% | $172M | -4.1 | -45.9% | — | Healthcare | -9.4% | -13% | ||
| 18 | PepGen Inc. | $1.93 | 7.2% | $133M | -0.9 | 15.1% | — | Healthcare | 34% | — | ||
| 19 | Korro Bio, Inc. | $12.59 | -3.4% | $112M | -1.3 | 21.7% | — | Healthcare | -28.7% | — | ||
| 20 | Precision BioSciences, Inc. | $7.45 | -2.4% | $96M | -2.1 | -57% | — | Healthcare | 32.8% | -11.9% | ||
| 21 | Metagenomi, Inc. Common Stock | $1.41 | 0% | $53M | -0.6 | -21.2% | — | Healthcare | -10.2% | -43.9% | ||
| 22 | Aligos Therapeutics, Inc. | $6.35 | -1.4% | $39M | -2.6 | 51.1% | — | Healthcare | 25.7% | -44.6% | ||
| 23 | Sangamo Therapeutics, Inc. | $0.18 | 31.6% | $38M | -0.4 | 41.3% | — | Healthcare | -75.3% | -37.1% | ||
| 24 | Exicure, Inc. | $3.40 | 1.8% | $22M | -2.1 | -209.2% | — | Healthcare | -68.3% | -100% | ||
| 25 | TransCode Therapeutics, Inc. | $7.86 | 1.6% | $7M | -0.2 | -647.4% | — | Healthcare | -33.6% | — | ||
| 26 | Phio Pharmaceuticals Corp. | $1.13 | -2.6% | $7M | -0.8 | -294107.8% | — | Healthcare | -39.9% | — | ||
| 27 | Silexion Therapeutics Ltd. | $0.60 | -4.8% | $2M | -0.1 | 309.5% | — | Healthcare | -96.1% | — | ||
| 28 | Silexion Therapeutics Ltd. | $0.02 | -1.3% | $49088 | -0.0 | 61.6% | — | Healthcare | -78.3% | — |
Showing 28 stocks